Effects of COVID 19 on Hospitalization Rate Among Diabetic People in Brazil
DOI:
https://doi.org/10.53819/81018102t5078Abstract
The study sought to examine the effects of COVID 19 on the hospitalization rate among diabetic people in Brazil. The study made conclusions based on the findings from the previous studies. The study findings indicated that People with diabetes are more likely to have severe complications from COVID-19. People with diabetes are more likely to have symptoms and complications when infected with any virus, but COVID 19 has been extreme. Individuals with persistent diseases like diabetic Mellitus, weight problems, hypertension, or cardiovascular cases are the most affected by COVID-19. Diabetic Mellitus is a severe problem that requires self-management and more disciplinary attention that consists of regular care to diet, exercise, blood sugar management and use of drugs. It is concluded that Patients with diabetes have been greatly affected by the COVID-19. The hospitalization rate has been high among patients that have diabetes. COVID-19 pandemic has led to health service modification and temporary disruption of the routine care provided to patients with diabetes mellitus (DM) in primary care. This is done to minimize outpatient visits, permit physical distancing, and ensure patients' and healthcare providers' safety. The study recommended that different measures to prevent COVID-19 are crucial for individuals with diabetes. People with diabetes need regular blood sugar management and compliance with ongoing medication, even when it comes to COVID-19 infection. It is important to remember that people with either type of diabetes can vary in age, their complications, and how well they have managed their diabetes. The government needs guidelines to guarantee accessibility to medicines and healthcare services among diabetic patients.
Keywords: Covid 19, hospitalization rate, diabetic people, Brazil
References
Bajgain, K. T., Badal, S., Bajgain, B. B., & Santana, M. J. (2021). Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. American Journal of Infection Control, 49(2), 238-246. https://doi.org/10.1016/j.ajic.2020.06.213
Ballivian, J., Alcaide, M. L., Cecchini, D., Jones, D. L., Abbamonte, J. M., & Cassetti, I. (2020). Impact of COVID-19-related stress and lockdown on mental health among people living with HIV in Argentina. Journal of Acquired Immune Deficiency Syndromes, 85(4), 475-482. https://doi.org/10.1097/QAI.0000000000002493
Biancalana, E., Parolini, F., Mengozzi, A., & Solini, A. (2021). Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study. Journal of Acta diabetologist, 58(4), 431-436. https://doi.org/10.1007/s00592-020-01637-y
Català, M., Alonso, S., Alvarez-Lacalle, E., López, D., Cardona, P. J., & Prats, C. (2020). Empirical model for short-time prediction of COVID-19 spreading. Plos computational biology, 16(12), 431-449. https://doi.org/10.1371/journal.pcbi.1008431
Deepa, N., Parveen, A., Khurshid, A., Ramachandran, M., Sathiyaraj, C., & Vimala, C. (2022, May). A study on issues and preventive measures taken to control Covid-19. In AIP Conference Proceedings (Vol. 2393, No. 1, p. 020226). AIP Publishing LLC. https://doi.org/10.1063/5.0075078
Erener, S. (2020). Diabetes, infection risk and COVID-19. Molecular metabolism, 39, 101044. https://doi.org/10.1016/j.molmet.2020.101044
Garg, S. K., Rodbard, D., Hirsch, I. B., & Forlenza, G. P. (2020). Managing new-onset type 1 diabetes during the COVID-19 pandemic: challenges and opportunities. Diabetes technology & therapeutics, 22(6), 431-439. https://doi.org/10.1089/dia.2020.0161
Gujral, U. P., Johnson, L., Nielsen, J., Vellanki, P., Haw, J. S., Davis, G. M., ... & Pasquel, F. J. (2020). Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks. BMJ Open Diabetes Research and Care, 8(1), e001520. https://doi.org/10.1136/bmjdrc-2020-001520
Kaplan Serin, E., & Bülbüloğlu, S. (2021). The effect of attitude to death on self-management in patients with type 2 diabetes mellitus during the COVID-19 pandemic. OMEGA-Journal of Death and Dying, 45(18), 389-396. https://doi.org/10.1177/00302228211020602
Kazakou, P., Lambadiari, V., Ikonomidis, I., Kountouri, A., Panagopoulos, G., Athanasopoulos, S., ... & Mitrakou, A. (2022). Diabetes and COVID-19; A Bidirectional Interplay. Frontiers in Endocrinology, 13 (2), 78-83. https://doi.org/10.3389/fendo.2022.780663
Liu, H., Chen, S., Liu, M., Nie, H., & Lu, H. (2020). Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging and disease, 11(3), 668-691. https://doi.org/10.14336/AD.2020.0502
Ludwig, S., & Zarbock, A. (2020). Coronaviruses and SARS-CoV-2: a brief overview. Anesthesia and analgesia. https://doi.org/10.1213/ANE.0000000000004845
Mantovani, A., Byrne, C. D., Zheng, M. H., & Targher, G. (2020). Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies. Nutrition, Metabolism and Cardiovascular Diseases, 30(8), 1236-1248. https://doi.org/10.1016/j.numecd.2020.05.014
Önmez, A., Gamsızkan, Z., Özdemir, Ş., Kesikbaş, E., Gökosmanoğlu, F., Torun, S., & Cinemre, H. (2020). The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes & Metabolic Syndrome. Clinical Research & Reviews, 14(6), 1963-1966. https://doi.org/10.1016/j.dsx.2020.10.007
Oriot, P., & Hermans, M. P. (2022). Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case-report and review of the literature. Acta Clinica Belgica, 77(1), 113-117. https://doi.org/10.1080/17843286.2020.1780390
Sheng, G., Chen, P., Wei, Y., Yue, H., Chu, J., Zhao, J., ... & Zhang, H. L. (2020). Viral infection increases the risk of idiopathic pulmonary fibrosis. Journal Chest, 157(5), 1175-1187. https://doi.org/10.1016/j.chest.2019.10.032
Smith, S. M., Boppana, A., Traupman, J. A., Unson, E., Maddock, D. A., Chao, K., ... & Connor, R. I. (2021). Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID‐19. Journal of medical virology, 93(1), 409-415. https://doi.org/10.1002/jmv.26227
Van Baar, A. C., Holleman, F., Crenier, L., Haidry, R., Magee, C., Hopkins, D., ... & Bergman, J. J. (2020). Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study. Gut, 69(2), 295-303. https://doi.org/10.1136/gutjnl-2019-318349
Vickery, K. D., Novotny, P. J., Ford, B. R., Lantz, K., Kavistan, S., Singh, D., ... & Wieland, M. L. (2022). Experiences of Hispanic Safety Net Clinic Patients with Diabetes During the COVID-19 Pandemic. The Science of Diabetes Self-Management and Care, 48(2), 87-97. https://doi.org/10.1177/26350106221076037
